Market Size, Share, Growth & Trends 2030

Immunofluorescence Assay Market

Immunofluorescence Assay Market By Product (Reagents, Kits, Antibodies, Instruments, and Consumables & Accessories), By Type (Direct Immunofluorescence and Indirect Immunofluorescence), By Disease (Cancer, Cardiovascular Disease, Autoimmune Disease, Infectious Disease, and Others), By End-use Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs and Hospital & Diagnostic Centers) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2030

Category: Biotechnology Report Format : PDF Pages: 159 Report Code: ZMR-5838 Published Date: Dec-2022 Status : Published
Market Size in 2021 Market Forecast in 2030 CAGR (in %) Base Year
USD 2.6 Billion USD 4.5 Billion 6.2% 2021

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Immunofluorescence Assay Market, (2022 - 2030) (USD Billion)
    • 2.2 Global Immunofluorescence Assay Market : snapshot
  • Chapter 3. Global Immunofluorescence Assay Market - Industry Analysis
    • 3.1 Immunofluorescence Assay Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing prevalence of chronic disease to drive the market growth
    • 3.3 Market Restraints
      • 3.3.1. The high cost of instruments used in immunofluorescence assay is expected to hamper the market growth
    • 3.4 Market Opportunities
      • 3.4.1. Increasing demand for immunofluorescence assay from developing economies to flourish the market growth
    • 3.5 Market Challenges
      • 3.5.1. The lack of skilled professionals is the major restraining factor for the market expansion
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By Type
      • 3.7.3 Market attractiveness analysis By Disease
      • 3.7.4 Market attractiveness analysis By End-use Industry
  • Chapter 4. Global Immunofluorescence Assay Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Immunofluorescence Assay Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Immunofluorescence Assay Market - Product Analysis
    • 5.1 Global Immunofluorescence Assay Market overview: By Product
      • 5.1.1 Global Immunofluorescence Assay Market share, By Product, 2021 and 2030
    • 5.2 Reagents
      • 5.2.1 Global Immunofluorescence Assay Market by Reagents, 2022 - 2030 (USD Billion)
    • 5.3 Kits
      • 5.3.1 Global Immunofluorescence Assay Market by Kits, 2022 - 2030 (USD Billion)
    • 5.4 Antibodies
      • 5.4.1 Global Immunofluorescence Assay Market by Antibodies, 2022 - 2030 (USD Billion)
    • 5.5 Instruments
      • 5.5.1 Global Immunofluorescence Assay Market by Instruments, 2022 - 2030 (USD Billion)
    • 5.6 Consumables & Accessories
      • 5.6.1 Global Immunofluorescence Assay Market by Consumables & Accessories, 2022 - 2030 (USD Billion)
  • Chapter 6. Global Immunofluorescence Assay Market - Type Analysis
    • 6.1 Global Immunofluorescence Assay Market overview: By Type
      • 6.1.1 Global Immunofluorescence Assay Market share, By Type, 2021 and 2030
    • 6.2 Direct Immunofluorescence
      • 6.2.1 Global Immunofluorescence Assay Market by Direct Immunofluorescence, 2022 - 2030 (USD Billion)
    • 6.3 Indirect Immunofluorescence
      • 6.3.1 Global Immunofluorescence Assay Market by Indirect Immunofluorescence, 2022 - 2030 (USD Billion)
  • Chapter 7. Global Immunofluorescence Assay Market - Disease Analysis
    • 7.1 Global Immunofluorescence Assay Market overview: By Disease
      • 7.1.1 Global Immunofluorescence Assay Market share, By Disease, 2021 and 2030
    • 7.2 Cancer
      • 7.2.1 Global Immunofluorescence Assay Market by Cancer, 2022 - 2030 (USD Billion)
    • 7.3 Cardiovascular Disease
      • 7.3.1 Global Immunofluorescence Assay Market by Cardiovascular Disease, 2022 - 2030 (USD Billion)
    • 7.4 Autoimmune Disease
      • 7.4.1 Global Immunofluorescence Assay Market by Autoimmune Disease, 2022 - 2030 (USD Billion)
    • 7.5 Infectious Disease
      • 7.5.1 Global Immunofluorescence Assay Market by Infectious Disease, 2022 - 2030 (USD Billion)
    • 7.6 Others
      • 7.6.1 Global Immunofluorescence Assay Market by Others, 2022 - 2030 (USD Billion)
  • Chapter 8. Global Immunofluorescence Assay Market - End-use Industry Analysis
    • 8.1 Global Immunofluorescence Assay Market overview: By End-use Industry
      • 8.1.1 Global Immunofluorescence Assay Market share, By End-use Industry, 2021 and 2030
    • 8.2 Pharmaceutical & Biotechnology Companies
      • 8.2.1 Global Immunofluorescence Assay Market by Pharmaceutical & Biotechnology Companies, 2022 - 2030 (USD Billion)
    • 8.3 Academic & Research Institutes
      • 8.3.1 Global Immunofluorescence Assay Market by Academic & Research Institutes, 2022 - 2030 (USD Billion)
    • 8.4 CROs
      • 8.4.1 Global Immunofluorescence Assay Market by CROs, 2022 - 2030 (USD Billion)
    • 8.5 Hospital & Diagnostic Centers
      • 8.5.1 Global Immunofluorescence Assay Market by Hospital & Diagnostic Centers, 2022 - 2030 (USD Billion)
  • Chapter 9. Immunofluorescence Assay Market - Regional Analysis
    • 9.1 Global Immunofluorescence Assay Market Regional Overview
    • 9.2 Global Immunofluorescence Assay Market Share, by Region, 2021 & 2030 (USD Billion)
    • 9.3. North America
      • 9.3.1 North America Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
        • 9.3.1.1 North America Immunofluorescence Assay Market, by Country, 2022 - 2030 (USD Billion)
    • 9.4 North America Immunofluorescence Assay Market, by Product, 2022 - 2030
      • 9.4.1 North America Immunofluorescence Assay Market, by Product, 2022 - 2030 (USD Billion)
    • 9.5 North America Immunofluorescence Assay Market, by Type, 2022 - 2030
      • 9.5.1 North America Immunofluorescence Assay Market, by Type, 2022 - 2030 (USD Billion)
    • 9.6 North America Immunofluorescence Assay Market, by Disease, 2022 - 2030
      • 9.6.1 North America Immunofluorescence Assay Market, by Disease, 2022 - 2030 (USD Billion)
    • 9.7 North America Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030
      • 9.7.1 North America Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030 (USD Billion)
    • 9.4. Europe
      • 9.4.2 Europe Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
        • 9.4.2.1 Europe Immunofluorescence Assay Market, by Country, 2022 - 2030 (USD Billion)
    • 9.4 Europe Immunofluorescence Assay Market, by Product, 2022 - 2030
      • 9.4.1 Europe Immunofluorescence Assay Market, by Product, 2022 - 2030 (USD Billion)
    • 9.5 Europe Immunofluorescence Assay Market, by Type, 2022 - 2030
      • 9.5.1 Europe Immunofluorescence Assay Market, by Type, 2022 - 2030 (USD Billion)
    • 9.6 Europe Immunofluorescence Assay Market, by Disease, 2022 - 2030
      • 9.6.1 Europe Immunofluorescence Assay Market, by Disease, 2022 - 2030 (USD Billion)
    • 9.7 Europe Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030
      • 9.7.1 Europe Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030 (USD Billion)
    • 9.5. Asia Pacific
      • 9.5.3 Asia Pacific Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
        • 9.5.3.1 Asia Pacific Immunofluorescence Assay Market, by Country, 2022 - 2030 (USD Billion)
    • 9.4 Asia Pacific Immunofluorescence Assay Market, by Product, 2022 - 2030
      • 9.4.1 Asia Pacific Immunofluorescence Assay Market, by Product, 2022 - 2030 (USD Billion)
    • 9.5 Asia Pacific Immunofluorescence Assay Market, by Type, 2022 - 2030
      • 9.5.1 Asia Pacific Immunofluorescence Assay Market, by Type, 2022 - 2030 (USD Billion)
    • 9.6 Asia Pacific Immunofluorescence Assay Market, by Disease, 2022 - 2030
      • 9.6.1 Asia Pacific Immunofluorescence Assay Market, by Disease, 2022 - 2030 (USD Billion)
    • 9.7 Asia Pacific Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030
      • 9.7.1 Asia Pacific Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030 (USD Billion)
    • 9.6. Latin America
      • 9.6.4 Latin America Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
        • 9.6.4.1 Latin America Immunofluorescence Assay Market, by Country, 2022 - 2030 (USD Billion)
    • 9.4 Latin America Immunofluorescence Assay Market, by Product, 2022 - 2030
      • 9.4.1 Latin America Immunofluorescence Assay Market, by Product, 2022 - 2030 (USD Billion)
    • 9.5 Latin America Immunofluorescence Assay Market, by Type, 2022 - 2030
      • 9.5.1 Latin America Immunofluorescence Assay Market, by Type, 2022 - 2030 (USD Billion)
    • 9.6 Latin America Immunofluorescence Assay Market, by Disease, 2022 - 2030
      • 9.6.1 Latin America Immunofluorescence Assay Market, by Disease, 2022 - 2030 (USD Billion)
    • 9.7 Latin America Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030
      • 9.7.1 Latin America Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030 (USD Billion)
    • 9.7. The Middle-East and Africa
      • 9.7.5 The Middle-East and Africa Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
        • 9.7.5.1 The Middle-East and Africa Immunofluorescence Assay Market, by Country, 2022 - 2030 (USD Billion)
    • 9.4 The Middle-East and Africa Immunofluorescence Assay Market, by Product, 2022 - 2030
      • 9.4.1 The Middle-East and Africa Immunofluorescence Assay Market, by Product, 2022 - 2030 (USD Billion)
    • 9.5 The Middle-East and Africa Immunofluorescence Assay Market, by Type, 2022 - 2030
      • 9.5.1 The Middle-East and Africa Immunofluorescence Assay Market, by Type, 2022 - 2030 (USD Billion)
    • 9.6 The Middle-East and Africa Immunofluorescence Assay Market, by Disease, 2022 - 2030
      • 9.6.1 The Middle-East and Africa Immunofluorescence Assay Market, by Disease, 2022 - 2030 (USD Billion)
    • 9.7 The Middle-East and Africa Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030
      • 9.7.1 The Middle-East and Africa Immunofluorescence Assay Market, by End-use Industry, 2022 - 2030 (USD Billion)
  • Chapter 10. Company Profiles
    • 10.1 Danaher
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Sino Biological Inc.
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Enzo Life Sciences Inc.
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Agilent Technologies Inc.
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 BD
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Merck KGaA
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 PerkinElmer Inc.
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Bio-Rad Laboratories Inc.
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 Abcam plc.
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Thermo Fisher Scientific Inc.
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 MaxVision Biosciences Inc
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments
    • 10.12 AESKU GROUP GmbH
      • 10.12.1 Overview
      • 10.12.2 Financials
      • 10.12.3 Product Portfolio
      • 10.12.4 Business Strategy
      • 10.12.5 Recent Developments
    • 10.13 Elabscience Inc.
      • 10.13.1 Overview
      • 10.13.2 Financials
      • 10.13.3 Product Portfolio
      • 10.13.4 Business Strategy
      • 10.13.5 Recent Developments
    • 10.14 EpiGentek Group
      • 10.14.1 Overview
      • 10.14.2 Financials
      • 10.14.3 Product Portfolio
      • 10.14.4 Business Strategy
      • 10.14.5 Recent Developments
    • 10.15 Abnova Corporation
      • 10.15.1 Overview
      • 10.15.2 Financials
      • 10.15.3 Product Portfolio
      • 10.15.4 Business Strategy
      • 10.15.5 Recent Developments
    • 10.16 J. Mitra & Co. Pvt. Ltd.
      • 10.16.1 Overview
      • 10.16.2 Financials
      • 10.16.3 Product Portfolio
      • 10.16.4 Business Strategy
      • 10.16.5 Recent Developments
    • 10.17 Celebs
      • 10.17.1 Overview
      • 10.17.2 Financials
      • 10.17.3 Product Portfolio
      • 10.17.4 Business Strategy
      • 10.17.5 Recent Developments
    • 10.18 Zyagen Inc.
      • 10.18.1 Overview
      • 10.18.2 Financials
      • 10.18.3 Product Portfolio
      • 10.18.4 Business Strategy
      • 10.18.5 Recent Developments
    • 10.19 Bruker Corporation
      • 10.19.1 Overview
      • 10.19.2 Financials
      • 10.19.3 Product Portfolio
      • 10.19.4 Business Strategy
      • 10.19.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Immunofluorescence Assay Market attractiveness, By Product
  • 6. Global Immunofluorescence Assay Market attractiveness, By Type
  • 7. Global Immunofluorescence Assay Market attractiveness, By Disease
  • 8. Global Immunofluorescence Assay Market attractiveness, By End-use Industry
  • 9. Global Immunofluorescence Assay Market share by Product, 2022 and 2030 (USD Billion)
  • 10. Global Immunofluorescence Assay Market by Reagents, 2022 - 2030 (USD Billion)
  • 11. Global Immunofluorescence Assay Market by Kits, 2022 - 2030 (USD Billion)
  • 12. Global Immunofluorescence Assay Market by Antibodies, 2022 - 2030 (USD Billion)
  • 13. Global Immunofluorescence Assay Market by Instruments, 2022 - 2030 (USD Billion)
  • 14. Global Immunofluorescence Assay Market by Consumables & Accessories, 2022 - 2030 (USD Billion)
  • 15. Global Immunofluorescence Assay Market share by Type, 2022 and 2030 (USD Billion)
  • 16. Global Immunofluorescence Assay Market by Direct Immunofluorescence, 2022 - 2030 (USD Billion)
  • 17. Global Immunofluorescence Assay Market by Indirect Immunofluorescence, 2022 - 2030 (USD Billion)
  • 18. Global Immunofluorescence Assay Market share by Disease, 2022 and 2030 (USD Billion)
  • 19. Global Immunofluorescence Assay Market by Cancer, 2022 - 2030 (USD Billion)
  • 20. Global Immunofluorescence Assay Market by Cardiovascular Disease, 2022 - 2030 (USD Billion)
  • 21. Global Immunofluorescence Assay Market by Autoimmune Disease, 2022 - 2030 (USD Billion)
  • 22. Global Immunofluorescence Assay Market by Infectious Disease, 2022 - 2030 (USD Billion)
  • 23. Global Immunofluorescence Assay Market by Others, 2022 - 2030 (USD Billion)
  • 24. Global Immunofluorescence Assay Market share by End-use Industry, 2022 and 2030 (USD Billion)
  • 25. Global Immunofluorescence Assay Market by Pharmaceutical & Biotechnology Companies, 2022 - 2030 (USD Billion)
  • 26. Global Immunofluorescence Assay Market by Academic & Research Institutes, 2022 - 2030 (USD Billion)
  • 27. Global Immunofluorescence Assay Market by CROs, 2022 - 2030 (USD Billion)
  • 28. Global Immunofluorescence Assay Market by Hospital & Diagnostic Centers, 2022 - 2030 (USD Billion)
  • 29. Global Immunofluorescence Assay Market share, by Region, 2022 and 2030
  • 30. North America Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
  • 31. Europe Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
  • 32. Asia Pacific Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
  • 33. Latin America Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)
  • 34. The Middle-East and Africa Immunofluorescence Assay Market, 2022 - 2030 (USD Billion)

Table Of Tables

  • 1. Global Immunofluorescence Assay Market: Snapshot
  • 2. Drivers of the Immunofluorescence Assay Market: impact analysis
  • 3. North America Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 4. North America Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 5. North America Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 6. North America Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 7. U.S. Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 8. U.S. Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 9. U.S. Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 10. U.S. Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 11. Canada Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 12. Canada Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 13. Canada Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 14. Canada Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 15. Europe Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 16. Europe Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 17. Europe Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 18. Europe Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 19. Germany Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 20. Germany Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 21. Germany Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 22. Germany Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 23. France Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 24. France Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 25. France Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 26. France Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 27. U.K. Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 28. U.K. Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 29. U.K. Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 30. U.K. Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 31. Italy Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 32. Italy Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 33. Italy Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 34. Italy Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 35. Spain Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 36. Spain Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 37. Spain Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 38. Spain Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 39. Rest of Europe Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 40. Rest of Europe Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 41. Rest of Europe Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 42. Rest of Europe Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 43. Asia Pacific Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 44. Asia Pacific Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 45. Asia Pacific Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 46. Asia Pacific Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 47. China Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 48. China Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 49. China Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 50. China Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 51. Japan Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 52. Japan Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 53. Japan Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 54. Japan Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 55. India Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 56. India Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 57. India Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 58. India Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 59. South Korea Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 60. South Korea Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 61. South Korea Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 62. South Korea Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 63. South-East Asia Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 64. South-East Asia Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 65. South-East Asia Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 66. South-East Asia Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 67. Rest of Asia Pacific Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 68. Rest of Asia Pacific Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 69. Rest of Asia Pacific Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 70. Rest of Asia Pacific Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 71. Latin America Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 72. Latin America Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 73. Latin America Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 74. Latin America Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 75. Brazil Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 76. Brazil Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 77. Brazil Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 78. Brazil Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 79. Mexico Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 80. Mexico Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 81. Mexico Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 82. Mexico Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 83. Rest of Latin America Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 84. Rest of Latin America Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 85. Rest of Latin America Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 86. Rest of Latin America Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 87. The Middle-East and Africa Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 88. The Middle-East and Africa Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 89. The Middle-East and Africa Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 90. The Middle-East and Africa Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 91. GCC Countries Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 92. GCC Countries Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 93. GCC Countries Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 94. GCC Countries Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 95. South Africa Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 96. South Africa Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 97. South Africa Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 98. South Africa Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)
  • 99. Rest of Middle-East Africa Immunofluorescence Assay Market revenue, By Product, 2022 - 2030 (USD Billion)
  • 100. Rest of Middle-East Africa Immunofluorescence Assay Market revenue, By Type, 2022 - 2030 (USD Billion)
  • 101. Rest of Middle-East Africa Immunofluorescence Assay Market revenue, By Disease, 2022 - 2030 (USD Billion)
  • 102. Rest of Middle-East Africa Immunofluorescence Assay Market revenue, By End-use Industry, 2022 - 2030 (USD Billion)

Methodology

FrequentlyAsked Questions

The surging research and development activities to innovate new ways of testing are boosting the growth of the global immunofluorescence assay market. Moreover, the increasing burden of diseases like neurological disorders, infectious diseases, cancer, diabetes, cardiovascular diseases, autoimmune diseases, and many others globally has positively shaped the trajectory of the global immunofluorescence assay market during the forecast period.

According to the report, the global immunofluorescence assay market size was worth around USD 2.6 billion in 2021 and is predicted to grow to around USD 4.5 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.2% between 2022 and 2030.

The global immunofluorescence assay market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market owing to the presence of key players, the high prevalence of diseases in the region, and established healthcare infrastructure are some of the key factors accountable for its large share in the market.

The global immunofluorescence assay market is dominated by players like Danaher, Sino Biological Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., BD, Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam plc., Thermo Fisher Scientific Inc., MaxVision Biosciences Inc, AESKU GROUP GmbH, Elabscience, Inc., EpiGentek Group, Abnova Corporation, J. Mitra & Co. Pvt. Ltd., Celebs, Zyagen, Inc., Bruker Corporation among others.

Choose License Type

  • zion payment modes

List of Contents

MarketSize Industry Analysis:OverviewTo know more about this report,request a sample copy.Growth DriversRestraintsOpportunitiesChallengesSegmentationRecent Developments:Market Report Scope:Regional AnalysisCompetitive AnalysisThe global immunofluorescence assay market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed